DRGEM Corporation (KOSDAQ:263690)
5,460.00
-20.00 (-0.36%)
At close: Feb 13, 2026
DRGEM Market Cap
DRGEM has a market cap or net worth of 59.49 billion as of February 13, 2026. Its market cap has decreased by -3.42% in one year.
Market Cap
59.49B
Enterprise Value
57.81B
Revenue
98.34B
Ranking
n/a
PE Ratio
7.38
Stock Price
5,460.00
Market Cap Chart
Since November 22, 2018, DRGEM's market cap has decreased from 76.56B to 59.49B, a decrease of -22.30%. That is a compound annual growth rate of -3.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 59.49B | 2.25% |
| Dec 30, 2025 | 58.18B | -6.54% |
| Dec 30, 2024 | 62.26B | -45.72% |
| Dec 28, 2023 | 114.68B | -1.79% |
| Dec 29, 2022 | 116.78B | -13.05% |
| Dec 30, 2021 | 134.30B | -29.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Remed | 95.97B |
| Noul Co.,Ltd. | 93.50B |
| QuantaMatrix | 81.69B |
| JPI Healthcare | 75.05B |
| Hironic | 74.74B |
| Neofect | 58.49B |
| Genoray | 54.42B |
| UXN Co., Ltd. | 40.45B |